M Bayes, X Rabasseda, JR Prous - Methods and findings in experimental and clinical …, 2006 - journals.prous.com Contributing Editors: P. Cole, C. Orellana, JA Vallès, RM a . Antonijoan, KP
Mohana Priya, M. Priya, V. Renuga, R. Sree Lekha, B. Priya, A. Tomillero, G.
Krithiga and E. Banu Rekha. Cited by 148 - Related articles - All 9 versions
- ►angrylapdog.com LA Fox, LM Buckloh, SD Smith, T Wysocki, N … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Eleven subjects from each group completed the trial (age 46.3 ± 3.2
months [means ± SE]). At baseline, there were no differences between groups in
HbA 1c , MBG, age, sex, diabetes duration, or parental QOL. Mean HbA 1c , ... Cited by 71 - Related articles - All 9 versions
- ►angrylapdog.com M Phillip, T Battelino, H Rodriguez, T Danne, … - Diabetes Care, 2007 - Am Diabetes Assoc Young patients with diabetes, their families, and their diabetes care providers
continue to be faced with the challenge of striving to maintain blood glucose
levels in the near-normal range. High blood glucose levels with elevated ... Cited by 43 - Related articles - BL Direct - All 7 versions
T Danne, T Battelino, O Kordonouri, R Hanas, … - Pediatr Diabetes, 2005 - interscience.wiley.com Danne T, Battelino T, Kordonouri O, Hanas R, Klinkert C, Ludvigsson J, Barrio R,
Aebi C, Gschwend S, Mullis P, Schumacher U, Schwitzgebel V, Zumsteg U, Morandi
A, Rabbone I, Cherubini V, Toni S, de Beaufort C, Hindmarsh P, Sumner A, ... Cited by 34 - Related articles - All 3 versions
GS Jeha, LP Karaviti, B Anderson, EOB … - Diabetes Technology & Therapeutics, 2005 - liebertonline.com Children's Nutrition Research Center, Houston, Texas. The contents of this
publication do not necessarily reflect the views of policies of the US
Department of Agricul- ture, nor does mention of trade names, commercial ... Cited by 32 - Related articles - BL Direct - All 3 versions
- ►sediabetes.org [PDF] K Jeitler, K Horvath, A Berghold, TW Gratzer, … - Diabetologia, 2008 - Springer Abstract Aims We compared the effects of continuous subcutaneous insulin
infusion (CSII) with those of multiple daily insulin (MDI) injections on
glycaemic control, risk of hypoglycae- mic episodes, insulin requirements ... Cited by 32 - Related articles - BL Direct - All 5 versions
R Hanas, J Ludvigsson - Pediatric Diabetes, 2006 - interscience.wiley.com Abstract: This review deals with the two most serious side effects encountered
with insulin pump therapy, severe hypoglycemia and diabetic ketoacidosis (DKA).
Although clinical follow-up studies reported decreased rates of severe ... Cited by 31 - Related articles - BL Direct - All 3 versions
KD Barnard, CE Lloyd, TC Skinner - Diabetic Medicine, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 27 - Related articles - BL Direct - All 6 versions
N Sulli, B Shashaj - Diabetic Medicine, 2006 - interscience.wiley.com Methods Forty-two patients (mean age 12.2 ± 3.4 years; range 4.5–17 years; 24
males; mean duration of Type 1 diabetes 5.1 ± 3.0 years) were studied. The
following parameters were assessed in the year before starting CSII ... Cited by 26 - Related articles - BL Direct - All 5 versions
